Crestor, containing rosuvastatin, is a widely prescribed statin medication for managing cholesterol levels. It lowers LDL (bad cholesterol) and triglycerides while raising HDL (good cholesterol), reducing the risk of cardiovascular complications such as heart attacks and strokes. It is a trusted choice for individuals at risk of heart disease or those with high cholesterol.
Benefits of Crestor:
Dosage:
Warnings and Precautions:
Usage Instructions:
Storage Information:
Common Side Effects:
More information about Crestor:
ReferencesCrestor® (rosuvastatin) is a member of a class of medications called statins. These medications are used to lower cholesterol and triglycerides while improving the quality of life for people with cholesterol levels near the target low. Crestor contains the active ingredient rosuvastatin, which works by blocking the enzyme that produces cholesterol. Without adequately controlling cholesterol levels, people with high cholesterol may experience an increase in cholesterol levels and possibly a decrease in the quality of life. To minimize the risk of cardiovascular events, people with high cholesterol can safely use Crestor.
AstraZeneca has agreed to pay $1.5bn (£1.3bn) in cash to settle a lawsuit against Pfizer, the world’s biggest drugmaker.
The $1.5bn settlement, which was announced in July last year, will cover up to $7.7bn of the drug’s sales from the global market.
It is the biggest drug-maker in the world, with a market share of around 90 per cent of its market size in Europe. AstraZeneca agreed to pay $1.5bn (£1.3bn) in cash to settle the lawsuit, while the Anglo-Swedish pharmaceutical company said it would pay $2.1bn in cash to settle the case.
The AstraZeneca settlement is set to go on hold for a further three years. The deal is likely to result in AstraZeneca agreeing to a settlement of more than 7m pounds, or 14.9 per cent of the total price of the $1.3bn drug.
The drug company is already facing lawsuits in over 50 countries. Pfizer, which makes the cholesterol-lowering drug Crestor, agreed to settle the lawsuits in 2010 in an agreement that was the final agreement.
Pfizer, which was founded in 1849, said its profits rose after the drug was withdrawn in 1997, but that it still had to pay cash for the sale of its own shares.
The company said the agreement had been made under the “fair use” provisions of the federal Trade Representative Act, which allows the courts to grant injunctions against unlawful conduct by a public official or insurer and to prevent others from taking advantage of them.
The agreement is part of a “fair use” plan in which Pfizer sells its products in a manner that is fair to the public and that is used in the development of its drugs.
The deal is expected to be completed by the end of 2010.
The settlement will have a “fair use” effect if the drug company agrees to divest its own shares in AstraZeneca, which is currently in the management of its own company, AstraZeneca, and split its revenue from the company.
The AstraZeneca agreement will allow Pfizer to pay AstraZeneca up to $3.5bn (about $5.5bn) in cash to settle the lawsuit. The settlement will also have a “fair use” effect if the drug company agrees to divest its own shares in AstraZeneca, while also making additional payments to AstraZeneca for the sale of its own stock.
The deal was reached after the drug company, known as AstraZeneca, signed an agreement in July 2011 to sell its own shares in its own company for $1.2bn, or 1.7 per cent of the total price of the drug.
The deal was reached after the drug company, known as AstraZeneca, agreed to sell its own shares in its own company for $1.2bn, or 1.7 per cent of the total price of the drug, which was $13.6bn in 2009.
The deal was reached after the drug company, known as AstraZeneca, agreed to sell its own stock for $1.2bn, or 1.7 per cent of the total price of the drug, which was $13.6bn in 2009.
The deal was reached after the drug company, known as AstraZeneca, signed an agreement in July 2011 to sell its own stock for $1.2bn, or 1.7 per cent of the total price of the drug, which was $13.6bn in 2009.
The deal was reached after the drug company, known as AstraZeneca, agreed to sell its own stock for $1.2bn, or 1.
The manufacturer of Crestor, the world’s best-known drug, announced this morning the loss of the exclusive rights to the drug to its makers.
“This is a major loss for the world’s leading pharmaceutical company,” said Richard M. Cohen, chairman, president, and chief executive officer of AstraZeneca. “This loss, however, is a significant blow to our global portfolio.”
The loss of exclusive rights to Crestor in the United States came after a recent study by AstraZeneca revealed that the average price of Crestor is $4.45 per pill. This was slightly higher than the average price of $2.55 per pill in the United States, according to the company’s website. According to the study, AstraZeneca reported that Crestor had a market share of around 8% in the United States.
AstraZeneca’s study revealed that the average price of Crestor is about $4.50 per pill. This was a slight increase from $3.30 per pill in the United States. This was the second time the company reported a loss for a pharmaceutical company to its manufacturer, which has a long history of failing to deliver significant health benefits to patients.
The manufacturer of Crestor, however, has been facing challenges with price increases. The company recently began selling a generic version of Crestor for a whopping $2.7 billion, which has led to a steep decline in sales of Crestor.
AstraZeneca, which markets a number of generic drugs, said it would be offering its generic version of the drug at a higher price. The company said it expects to launch the generic version in the first half of 2011. The generic version will cost around $100,000 and will be available through its distributors network in the United States.
Crestor has been on the market since its launch. AstraZeneca’s Crestor has been on the market for almost two decades. In the late 1990s, Crestor was approved for use in the United States as a treatment for Alzheimer’s disease. Today, Crestor is used to treat more than 300,000 people with dementia, and is marketed under the brand name Crestor.
Crestor has not been approved by the Food and Drug Administration (FDA) for marketing in the United States. The company has been in the market for more than a decade to market a number of products to its customers. The company was the first company to launch a generic version of Crestor in the United States.
The company has a history of failing to deliver significant health benefits to patients. Crestor is one of the most well-known drugs in the world, with sales of $2.3 billion in the United States in 2008.
Originally developed by AstraZeneca, Crestor has been in the research and development stages since it was first introduced. It has been approved for marketing for a number of years.
In 2010, AstraZeneca acquired the rights to market a number of products for the treatment of Alzheimer’s disease in the United States. In February 2011, AstraZeneca acquired the rights to market a number of products for the treatment of Alzheimer’s disease in the United States. Crestor, however, has been in the research and development stages since it was first marketed in the United States.
AstraZeneca’s Crestor is marketed under the name Crestor and is available in more than 30 countries worldwide. Crestor is approved for marketing in the United States and Europe. Crestor is also available in Canada and Europe.
Crestor is a widely used drug for its well-known cholesterol-lowering properties, and has been approved for marketing in more than 30 countries worldwide.
The company has also been in the research and development stages since it was first approved for marketing in the United States. Crestor was the first drug to receive FDA approval for the treatment of Alzheimer’s disease in the United States.
The Crestor is also available in the United States as an extended-release tablet, with the active ingredient rosuvastatin, being the only FDA-approved drug for this purpose. Crestor is not available in Canada and Europe.
The company is not currently working with AstraZeneca to market its generic version of Crestor in the United States.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$12.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
How to get information on healthylifeProduct name: Rosuvastatin (20mg) |
| Report options |
| Search for prescriptions |
| Browse existing medicines |
| Browse medicines |
| Find specific healthylife medicines |
| Search healthylife brands |
| Search healthylife brand |
| Search healthylife medication |
| Search healthylife product |
| Search healthylife ingredient |
| Read product information |
Healthylife containsWARNINGS:
These ingredients may increase the risk of developing a heart attack or stroke. This risk may be increased if you also take other medicines containing these ingredients:
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$14.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
What is Crestor Rosuvastatin (20mg) used for? Crestor Rosuvatin (20mg) is a prescription only medication used to treat high cholesterol in postmenopausal women. It is also known as a statin drug.
Stade de France Pharmacy